Reviewing Epidural Steroid Lawsuits for Meningitis
Marc J. Bern & Partners and its professional team are reviewing potential lawsuits for individuals throughout the United States who experienced problems after receiving a recalled epidural steroid injection mixed by the New England Compounding Center.
An epidural steroid recall was issued in October 2012, amid a national outbreak of fungal meningitis linked to the compounding pharmacy, which distributed injections nationwide.
Financial compensation may be available through an epidural steroid fungal meningitis lawsuit for individuals who have experienced any of the following problems after receiving a recalled injection from New England Compounding Center:
- Fungal Meningitis Diagnosis
- Hospitalization for Meningitis Symptoms
- Spinal Osteomyelitis, Epidural Abscess or Infection at the Injection Site
- Septic Athritis
- Wrongful Death
To review a potential claim for yourself, a friend or family member, request a free consultation and claim evaluation.
FUNGAL MENINGITIS EPIDURAL STEROID OUTBREAK
In late September 2012, federal and state health experts first identified a multistate fungal meningitis outbreak, which has been linked to epidural injections of the steroid methylprednisolone acetate, which is used to treat back pain through direct spinal injection.
According to federal health investigators, an estimated 13,000 people nationwide may be at risk of meningitis risk after an epidural injection given since May 2012.
It may take up to a month for the fungal meningitis problems to surface following an epidural injection, with symptoms commonly starting with:
- Severe Headaches
EPIDURAL INJECTION RECALL DUE TO MENINGITIS PROBLEMS
It has been discovered that potentially contaminated epidural shots were administered throughout the United States between May 2012 and October 2012, when a nationwide recall was issued for all compounded drugs mixed by the New England Compounding Center.
The recalled epidural injection was distributed to an estimated 75 hospitals and pain management centers in at least 23 states. The U.S. Centers for Disease Control & Prevention (CDC) has issued a map tracking all hospitals and clinics that received the recalled epidural steroid injections.
Because of the long latency period that could occur between receiving the epidural steroid injection and meningitis symptoms, the number of people diagnosed with fungal meningitis continues to increase.
Unfortunately, it appears that these severe and potentially fatal injuries could have been prevented if the proper standards of care had been followed.
STEROID INJECTION FUNGAL MENINGITIS CLASS ACTION SUIT
Individual cases and potential fungal meningitis class action lawsuits are being reviewed by Marc J. Bern & Partners and its professional team for patients who experienced problems throughout the United States.
Free claim evaluations and legal consultations are provided by our epidural steroid recall lawyers to help determine if financial compensation may be available.
All cases are reviewed by our product liability law firm on a contingency fee basis, which means that there are no out-of-pocket expenses to hire a lawyer and there no attorney fees unless a recovery is obtained.